Abbisko Cayman (HKSE:02256) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Abbisko Cayman FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Abbisko Cayman's Free Cash Flow for the six months ended in Dec. 2023 was HK$-240.68 Mil. Abbisko Cayman's Revenue for the six months ended in Dec. 2023 was HK$0.00 Mil. Therefore, Abbisko Cayman's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Abbisko Cayman's current FCF Yield % is -21.78%.

The historical rank and industry rank for Abbisko Cayman's FCF Margin % or its related term are showing as below:

HKSE:02256' s FCF Margin % Range Over the Past 10 Years
Min: -2397.63 Med: -1600.19 Max: -802.74
Current: -2397.63

During the past 5 years, the highest FCF Margin % of Abbisko Cayman was -802.74%. The lowest was -2397.63%. And the median was -1600.19%.

HKSE:02256's FCF Margin % is ranked worse than
83.22% of 1037 companies
in the Biotechnology industry
Industry Median: -147.18 vs HKSE:02256: -2397.63

Abbisko Cayman FCF Margin % Historical Data

The historical data trend for Abbisko Cayman's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbisko Cayman FCF Margin % Chart

Abbisko Cayman Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-802.74

-2,397.63

Abbisko Cayman Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-336.64	-	-	-1,243.12	-

Competitive Comparison of Abbisko Cayman's FCF Margin %

For the Biotechnology subindustry, Abbisko Cayman's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbisko Cayman's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abbisko Cayman's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Abbisko Cayman's FCF Margin % falls into.

Abbisko Cayman FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Abbisko Cayman's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-499.833	/	20.847
	=	-2,397.63 %

Abbisko Cayman's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-240.68	/	0
	=	%

Abbisko Cayman FCF Margin % Related Terms

Thank you for viewing the detailed overview of Abbisko Cayman's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbisko Cayman (HKSE:02256) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abbisko Cayman Ltd (HKSE:02256) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

8ZD:Germany

Address

Building 3, No. 898 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN

Website

https://www.abbisko.com

Abbisko Cayman Ltd is a investment holding company it operates through its subsidiaries which is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative and differentiated small molecule oncology therapies. The company has only one business segment which is the development of innovative medicines.

Abbisko Cayman (HKSE:02256) Headlines

No Headlines